Numerous detection products in the "post-epidemic era" have steadily gained popularity due to the pattern of flu-like outbreaks. Agnitio Science & Technology, which develops IVD reagents "using microfluidic technology," received a special approval of manufacturing license for the "Baimin Analysis SARS-CoV-2 IgG Antibody Detection Kit" from the Ministry of Health and Welfare in December, 2021. Agnitio revealed that it has established a joint venture with BioAb, a division of Biotools, and its strategic partner, Croyez Bioscience, in Taiwan to decrease the supply chain distance, stabilize the quality of raw materials, and strengthen localized manufacturing in order to control the supply chain of essential antibody and antigen raw materials.

Original Source from Global Bio & Investment